FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for the generic Sumatriptan and Naproxen Sodium from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SUMATRIPTAN AND NAPROXEN SODIUM (Sumatriptan and Naproxen Sodium)

Snippet

SUPPL AP for SUMATRIPTAN AND NAPROXEN SODIUM (SUMATRIPTAN AND NAPROXEN SODIUM)